CD8A and COVID-19: investigated memory T cells in a cohort of COVID-19 cases with broad range of severity and found 70% of subjects had SARS-CoV-2 memory CD8+ T cell and 93% had memory CD4+ T cell 1 month post-symptoms onset (20–50 days) (17).